Mehis Pǒld

1.8k total citations
20 papers, 1.5k citations indexed

About

Mehis Pǒld is a scholar working on Pharmacology, Oncology and Genetics. According to data from OpenAlex, Mehis Pǒld has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 9 papers in Oncology and 9 papers in Genetics. Recurrent topics in Mehis Pǒld's work include Inflammatory mediators and NSAID effects (13 papers), Estrogen and related hormone effects (9 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Mehis Pǒld is often cited by papers focused on Inflammatory mediators and NSAID effects (13 papers), Estrogen and related hormone effects (9 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Mehis Pǒld collaborates with scholars based in United States, Poland and Estonia. Mehis Pǒld's co-authors include Steven M. Dubinett, Sherven Sharma, Mariam Dohadwala, Kostyantyn Krysan, Jie Luo, Ying Lin, Raj K. Batra, Robert Vescio, James R. Berenson and Chun‐Hsin Wu and has published in prestigious journals such as Science, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Mehis Pǒld

20 papers receiving 1.4k citations

Peers

Mehis Pǒld
Gargi D. Basu United States
Nicole R. Murray United States
Steven Seaman United States
Caishu Deng United States
Feng Bi China
Gargi D. Basu United States
Mehis Pǒld
Citations per year, relative to Mehis Pǒld Mehis Pǒld (= 1×) peers Gargi D. Basu

Countries citing papers authored by Mehis Pǒld

Since Specialization
Citations

This map shows the geographic impact of Mehis Pǒld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehis Pǒld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehis Pǒld more than expected).

Fields of papers citing papers by Mehis Pǒld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehis Pǒld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehis Pǒld. The network helps show where Mehis Pǒld may publish in the future.

Co-authorship network of co-authors of Mehis Pǒld

This figure shows the co-authorship network connecting the top 25 collaborators of Mehis Pǒld. A scholar is included among the top collaborators of Mehis Pǒld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehis Pǒld. Mehis Pǒld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, K A, Zhiyong Qiu, R. Wong, et al.. (2010). Multivalent immunity targeting tumor-associated antigens by intra-lymph node DNA-prime, peptide-boost vaccination. Cancer Gene Therapy. 18(1). 63–76. 9 indexed citations
2.
Heuzé‐Vourc'h, Nathalie, Harnisha Dalwadi, Felicita Baratelli, et al.. (2005). IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression. Biochemical and Biophysical Research Communications. 333(2). 470–475. 35 indexed citations
3.
Pǒld, Mehis, Li Zhu, Sherven Sharma, et al.. (2004). Cyclooxygenase-2 dependent expression of angiogenic CXC chemokines, ENA-78/CXCL5 and IL-8/CXCL8, in human non-small cell lung cancer. Cancer Research. 64. 1142–1142. 1 indexed citations
4.
Riedl, Karen, Kostyantyn Krysan, Mehis Pǒld, et al.. (2004). Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resistance Updates. 7(3). 169–184. 74 indexed citations
5.
Krysan, Kostyantyn, Mariam Dohadwala, Jie Luo, et al.. (2004). Cyclooxygenase-2–Dependent Expression of Survivin in Non-small Cell Lung Cancer. CHEST Journal. 125(5). 140S–140S. 6 indexed citations
6.
Krysan, Kostyantyn, Harnisha Dalwadi, Sherven Sharma, Mehis Pǒld, & Steven M. Dubinett. (2004). Cyclooxygenase 2-Dependent Expression of Survivin Is Critical for Apoptosis Resistance in Non-Small Cell Lung Cancer. Cancer Research. 64(18). 6359–6362. 100 indexed citations
7.
Pǒld, Mehis, Kostyantyn Krysan, Mariam Dohadwala, et al.. (2004). Cyclooxygenase-2 Modulates the Insulin-Like Growth Factor Axis in Non–Small-Cell Lung Cancer. Cancer Research. 64(18). 6549–6555. 33 indexed citations
8.
Pǒld, Mehis, Li Zhu, Sherven Sharma, et al.. (2004). Cyclooxygenase-2-Dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/CXCL8 in Human Non-Small Cell Lung Cancer. Cancer Research. 64(5). 1853–1860. 110 indexed citations
9.
Dubinett, Steven M., Sherven Sharma, Min Huang, et al.. (2003). Cyclooxygenase-2 in Lung Cancer. PubMed. 37. 138–162. 34 indexed citations
10.
Sharma, Sherven, Min Huang, Mariam Dohadwala, et al.. (2003). Cyclooxygenase 2-Dependent Regulation of Antitumor Immunity in Lung Cancer. Lung Cancer. 75. 723–736. 4 indexed citations
11.
Batra, Raj K., Ying Lin, Sherven Sharma, et al.. (2003). Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism.. PubMed. 63(3). 642–6. 22 indexed citations
12.
Krysan, Kostyantyn, Li Zhu, Mariam Dohadwala, et al.. (2003). COX‐2‐dependent stabilization of survivin in non‐small cell lung cancer. The FASEB Journal. 18(1). 206–208. 117 indexed citations
13.
Dohadwala, Mariam, Raj K. Batra, Jie Luo, et al.. (2002). Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion. Journal of Biological Chemistry. 277(52). 50828–50833. 216 indexed citations
14.
Pǒld, Mehis, Mariam Dohadwala, Jie Luo, Ying‐Chun Lin, & Steven M. Dubinett. (2002). Microarray Identifies Cyclo-oxygenase-2–Dependent Modulation of Insulin-like Growth Factor Binding Protein-3 in Non-small Cell Lung Cancer Cells. CHEST Journal. 121(3). 29S–30S. 4 indexed citations
15.
Dohadwala, Mariam, Jie Luo, Li Zhu, et al.. (2001). Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44. Journal of Biological Chemistry. 276(24). 20809–20812. 195 indexed citations
16.
Pǒld, Mehis, et al.. (2000). Cloning of the first invertebrate MAGE paralogue: an epitope that activates T-cells in humans is highly conserved in evolution. Developmental & Comparative Immunology. 24(8). 719–731. 11 indexed citations
17.
Sjak-Shie, Nelida, Robert Vescio, Michael Kaminsky, et al.. (2000). Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: a shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma.. PubMed. 6(11). 4226–33. 11 indexed citations
18.
Pǒld, Mehis, et al.. (1999). Identification of a New, Unorthodox Member of the MAGE Gene Family. Genomics. 59(2). 161–167. 68 indexed citations
19.
Rettig, Matthew B., Robert Vescio, Mehis Pǒld, et al.. (1997). Kaposi's Sarcoma-Associated Herpesvirus Infection of Bone Marrow Dendritic Cells from Multiple Myeloma Patients. Science. 276(5320). 1851–1854. 371 indexed citations
20.
Rägo, Lembit, Raul‐Allan Kiivet, Jaanus Harro, & Mehis Pǒld. (1989). Central- and peripheral-type benzodiazepine receptors: Similar regulation by stres and GABA receptor agonists. Pharmacology Biochemistry and Behavior. 32(4). 879–883. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026